Prepared polygonatum kingianum as well as extract and application thereof
A multi-step extraction process using Job's tears steaming and a large-leaf Solomon's seal extract rich in fructan derivatives was prepared, which solved the problems of side effects and low activity in the processing of large-leaf Solomon's seal extract, and achieved more efficient bioactivity and multifunctional effects.
Patent Information
- Application Number
- CN202411037277.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-12
AI Technical Summary
Existing processing techniques for Polygonatum sibiricum have side effects such as diarrhea. The extraction process is complex, the components are limited, the activity is low, and the function is singular, making it ineffective in preventing Alzheimer's disease and enhancing memory.
The extract was prepared by steaming Coix seed to obtain Polygonatum macrocephala, and then steaming the Coix seed juice, followed by reflux extraction, activated carbon decolorization, dialysis and column chromatography to obtain extracts rich in fructan derivatives, including Coix seed-processed Polygonatum macrocephala extracts I, II, III and polysaccharides.
It eliminates the side effect of diarrhea, significantly improves the bioactivity of Polygonatum macrocephala, and enhances its functions such as lowering blood sugar, preventing Alzheimer's disease, enhancing memory, anti-oxidation and anti-fatigue. It is also low in cost and highly safe.
Smart Images

Figure CN118924843A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of Polygonatum cyrtonema, and particularly relates to a prepared Polygonatum cyrtonema and an extract thereof and an application thereof. Background Art
[0002] Large-leaf Polygonatum is a variant of Yunnan Polygonatum (Flora of China, 1978), also known as: tiger ginger, chicken claw ginseng, etc. It has the functions of replenishing qi and nourishing yin, strengthening the spleen, moistening the lungs, and benefiting the kidneys. It is used for spleen and stomach qi deficiency, fatigue, insufficient stomach yin, dry mouth and poor appetite, lung deficiency and dry cough, cough and hemoptysis due to fatigue, insufficient essence and blood, soreness of waist and knees, premature graying of hair, internal heat and thirst (hypoglycemic) and so on (Chinese Pharmacopoeia). The name of "dementia" was first recorded in the "Secret Biography of Hua Tuo, the Divine Doctor" in the Han Dynasty. Memory loss and forgetfulness are the core symptoms of "dementia". Alzheimer's disease is located in the brain and has a close relationship with the kidneys. Large-leaf Polygonatum has the function of "benefiting the kidneys" and has a significant effect in preventing Alzheimer's disease, especially the large-leaf Polygonatum processed by nine steaming and nine drying is more effective.
[0003] The raw product of large-leaf Polygonatum has certain irritation and side effects, and also has a certain peculiar smell, which needs to be improved through processing (Dong Baohua et al., The evolution of processing of Polygonatum and modern research progress, Chinese Journal of Traditional Chinese Medicine, V20(11): 213, 2022). The processing technology and process of Polygonatum are relatively simple, mainly "nine steaming and nine drying" (or long steaming and long drying) to enhance its efficacy; or use black beans to strengthen its kidney-tonifying effect; or use wine to improve its taste. After processing, large-leaf Polygonatum is a very safe food with no toxic side effects, but clinically, a small number of people have adverse reactions such as mild abdominal distension or diarrhea after taking Polygonatum (Doctor Bohe, 2019), which can be avoided if taken after meals.
[0004] In the document "Wang Qiuli. Study on the anti-inflammatory and hypoglycemic effects of crude polysaccharides from raw and nine-steamed products of Polygonatum cyrtonema (Master's thesis of Anhui University of Traditional Chinese Medicine, 2020)", fresh Polygonatum cyrtonema slices were continuously steamed and dried to 80% dry, repeated 9 times to obtain the nine-steamed product, which was not much different from fresh Polygonatum cyrtonema in anti-inflammatory and hypoglycemic effects, but the polysaccharide content of Polygonatum cyrtonema was reduced during the steaming process, and the polysaccharide content extracted after steaming was low and the extraction rate was low; the prior art has abundant research literature on the ability of Polygonatum cyrtonema polysaccharides to enhance memory and prevent Alzheimer's disease, and in the publication number CN115043957A, In the invention patent entitled "A Polygonatum sibiricum Polysaccharide and Its Preparation Method and Use", dried Polygonatum sibiricum powder is subjected to water extraction and alcohol precipitation to obtain Polygonatum sibiricum polysaccharide extract, and then Sevage reagent is used to remove the protein in the Polygonatum sibiricum polysaccharide extract to obtain crude Polygonatum sibiricum polysaccharide. The crude Polygonatum sibiricum polysaccharide is separated and purified by cellulose column and gel chromatography column in turn to obtain homogenized Polygonatum sibiricum polysaccharide, which has the functions of improving memory function, reducing β-amyloid protein deposition in the brain, restoring the homeostasis of the host's intestinal flora, and promoting the growth of probiotics. Its shortcomings are: complicated extraction process, single component, low extraction rate, low activity, and single function. Summary of the invention
[0005] In order to solve the problems in the prior art, the present invention provides a processed large-leaf Polygonatum and its extract and application, so as to eliminate all adverse reactions such as diarrhea. The processed large-leaf Polygonatum with coix seed and its extract have the effects of lowering blood sugar, preventing Alzheimer's disease, enhancing memory, anti-oxidation, anti-fatigue, delaying aging and beautifying.
[0006] The present invention solves the technical problem by adopting the following technical solutions:
[0007] The invention aims to provide a prepared large-leaf polygonatum sibiricum, which is prepared by steaming the large-leaf polygonatum sibiricum with coix seeds.
[0008] Coix seeds are sweet, light and cool, and enter the spleen, stomach and lung meridians. They have the functions of diuresis, spleen invigoration and diarrhea relief, numbness removal, pus discharge, detoxification and stagnation removal (Chinese Pharmacopoeia). Using coix seeds to process polygonatum can eliminate the side effects such as "heat" in the process of steaming polygonatum and "diarrhea" caused by processing. However, so far, there is no processing technology for processing polygonatum with coix seeds.
[0009] Furthermore, the method for processing Polygonatum sibiricum with coix seeds is as follows: wash and slice fresh Polygonatum sibiricum, and dehydrate to a moisture content of less than 50%; then mix evenly with 0.01-2% of coix seeds juice based on Polygonatum sibiricum, and steam for 10-30 hours; dehydrate the steamed Polygonatum sibiricum (at 60°C) to a moisture content of less than 50%, thereby obtaining processed Polygonatum sibiricum, which contains more than 5% of polyfructose derivatives.
[0010] A prepared Polygonatum cyrtonema extract, wherein the Polygonatum cyrtonema extract is separated and found to contain polyfructose derivatives (Polyfructose, PF, Polygonatum cyrtonema youth factor), wherein the molecular weight of the typical representative thereof is 828, and the polyfructose derivatives are mainly composed of β-pyranose, β-furanose and α-furanose, and the structural formula thereof is as follows:
[0011]
[0012] Further, the extraction method of the extract comprises the following steps:
[0013] Step 1: Preparation of Extract I: reflux extraction of Polygonatum cyrtonema steamed with coix seeds and then concentrate to obtain Coix seeds-prepared Polygonatum cyrtonema extract I;
[0014] Step 2: Preparation of Extract II: Decolorizing Extract I by stirring with activated carbon to obtain Coix Seed-processed Polygonatum cyrtonema Extract II;
[0015] Step 3: Preparation of Extract III: Concentrate Extract II after dialyzing to obtain Coix Seed-processed Polygonatum cyrtonema Extract III;
[0016] Step 4: Preparation of Polygonatum cyrtonemae polysaccharide prepared from coix seed, extracting extract III with a chromatography column and eluting, collecting the eluate with polysaccharide elution peak, dialyzing and freeze-drying to obtain Polygonatum cyrtonemae polysaccharide prepared from coix seed.
[0017] Furthermore, in step 1, 3-10 times the amount of water is used to reflux extract the steamed Polygonatum cyrtonema with coix seeds for 1 hour, and filtered; the residue is reflux extracted with 3-10 times the amount of water for 30 minutes, and filtered; the residue is extracted again once; the three extracts are combined; and the reduced pressure is concentrated to a paste, which is the Polygonatum cyrtonema prepared from coix seeds extract I, and the Polygonatum cyrtonema prepared from coix seeds extract I contains more than 5% PF.
[0018] Furthermore, in step 2, extract I is dissolved in water to prepare a 10% solution, and 0.01-1% activated carbon is used for decolorization at 40-90°C for 10-60 minutes by stirring, and filtered; the coix seed processed Polygonatum cyrtonema extract II is obtained, and the processed Polygonatum cyrtonema extract II contains more than 7% PF.
[0019] Furthermore, in step three, the coix seed-processed large-leaf Polygonatum cyrtonema extract II is dissolved in water; then dialyzed with a dialysis bag with a dialysis molecular weight of 200, and the solution in the dialysis bag is collected; the solution in the dialysis bag is dialyzed with a dialysis bag with a dialysis molecular weight of 5000, and the solution outside the dialysis bag is collected, and concentrated to dryness at low temperature to obtain the coix seed-processed large-leaf Polygonatum cyrtonema extract III, which contains more than 50% PF.
[0020] Furthermore, in step four, the coix seed-processed large-leaf Polygonatum cyrtone extract III is dissolved with ultrapure water, and then loaded onto a Sephadex G-25 chromatography column placed in a 4°C chromatography cabinet, and eluted with ultrapure water. The flow rate during elution is controlled at 0.5 mL / min, and 10 mL of eluate is collected in each tube. Then, the sugar is detected at 490 nm by the sulfuric acid-anthrone method tube by tube, and the tubes with polysaccharide peaks are collected and merged to obtain eluates 1, 2, 3, and 4, among which eluate peak 4 is the main peak. Eluate 4 is loaded into a dialysis bag with a molecular weight cutoff of 100 Da, and dialyzed with 10 times the amount of ultrapure water for 1 day, and the water is changed every 3 hours, and then freeze-dried to obtain coix seed-processed large-leaf Polygonatum cyrtone polysaccharide.
[0021] The invention discloses an application of a processed polygonatum sibiricum or a processed polygonatum sibiricum extract in preparing medicines for beauty, delaying aging, enhancing memory, preventing senile dementia, resisting oxidation, resisting fatigue, lowering blood sugar and the like.
[0022] Furthermore, the dosage form of the above-mentioned medicine is tablets, granules, capsules, oral liquid dosage forms, injections, ointments, suppositories, aerosols, and traditional Chinese medicines.
[0023] Compared with the prior art, the beneficial technical effects of the present invention are:
[0024] 1. After the large-leaf Polygonatum is processed by the technical process of the present invention, all adverse reactions such as diarrhea caused by it are completely eliminated, and the biological activity such as hypoglycemic is significantly improved. Compared with the traditional large-leaf Polygonatum processing process, this technology has lower cost, higher safety, better biological activity, and better product taste and quality.
[0025] 2. The extract obtained by the present invention is rich in polygonatum polysaccharide (PF), which is rarely or even absent in fresh and raw polygonatum. This component is a newly produced component in the processing of polygonatum. Its biological activities such as beauty, anti-aging, memory enhancement, prevention of Alzheimer's disease, anti-oxidation, anti-fatigue, and hypoglycemic are better than those of polygonatum polysaccharide, and it is one of the main active ingredients in the processing of polygonatum.
[0026] 3. The processed Polygonatum cyrtonema and its extract obtained by the present invention can be used directly in the form of processed Polygonatum cyrtonema, or can be developed into various dosage forms such as tablets and granules in the form of extracts.
[0027] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention, it can be implemented according to the contents of the specification. In order to make the above contents of the present invention and its objectives, features and advantages more obvious and easy to understand, the specific implementation methods of the present invention are listed below. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 This is the gel separation pattern of PF separation of the present invention.
[0029] Figure 2 This is the gel chromatogram (GPC) of the PF of the present invention.
[0030] Figure 3 High-resolution mass spectrometry to determine the molecular weight of PF.
[0031] Figure 4 Gas chromatography to determine PF composition.
[0032] Figure 5 It is the hydrogen spectrum of PF of the present invention.
[0033] Figure 6 is the carbon spectrum of the PF of the present invention.
[0034] Figure 7 This is the methylation gas chromatography-mass spectrometry spectrum of PF of the present invention.
[0035] Figure 8 This is the molecular structure of a typical representative molecule of PF (828). DETAILED DESCRIPTION
[0036] The technical solution of the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary illustrations and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0037] In addition, unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0038] Example 1: Preparation of Polygonatum sibiricum processed from Coix seeds and its extract
[0039] The specific steps are as follows:
[0040] 1) Preparation of Polygonatum cyrtonema prepared from Coix seeds:
[0041] A) 5 kg fresh Polygonatum cyrtonema, clean and slice;
[0042] B) drying the Polygonatum sibiricum tablets at 80°C to a moisture content of 10%;
[0043] C) Dissolve 100g of coix seed in 1000g of water and decoct the juice, then evenly spray it on the large-leafed polygonatum to allow it to fully absorb;
[0044] D) Then place it in a steaming container and steam for 10 hours (100°C);
[0045] E), drying and dehydrating the steamed polygonatum at 40° C. to a moisture content of 10%, to obtain coix seed-processed large-leaf polygonatum.
[0046] 2) Crude extraction (extract I): Take the prepared Polygonatum cyrtonema from coix seeds in step 1), dry it at 40°C to a moisture content of 10%, grind it through a 2-mesh sieve, take 1000g of the prepared Polygonatum cyrtonema powder, reflux extract it with 10 times the amount of distilled water for 1h, and filter it; extract it three times in a row; combine the extracts, and concentrate them to dryness under reduced pressure to obtain extract I (750g) with a PF content of more than 5%.
[0047] 3) Decolorization (Extract II): Extract I (750 g) was dissolved in 10 times the volume (V / W) of distilled water, 0.75 g of activated carbon (0.01%) was added, and the mixture was stirred and decolorized at 90°C for 10 minutes. The mixture was filtered to obtain Extract II (605 g) with a PF content of more than 7%.
[0048] 4) Preparation of Extract III: Take 400 g of Extract II and dissolve it in 1000 mL of distilled water. Dialyze it with a dialysis bag with a dialysis molecular weight of 200, and collect the solution inside the dialysis bag; then, dialyze it with a dialysis bag with a dialysis molecular weight of 5000, collect the solution outside the dialysis bag, concentrate it under reduced pressure, and finally freeze-dry it to obtain Extract III (65 g) with a PF content of more than 50%.
[0049] 5) Preparation of Polygonatum cyrtonema polysaccharide (PF): Extract III was dissolved in 2 mmol / L Tris-HCl buffer solution with a pH of 7.2, and then loaded onto a Sephadex G-50 chromatography column placed in a 4°C chromatography cabinet and eluted with 2.0 mmol / L Tris-HCl buffer solution. The flow rate was controlled at 0.5 mL / min during elution, and 10 mL of eluate was collected in each tube. Sugars were then detected at 490 nm using the sulfuric acid-anthrone method tube by tube. The tubes with the highest polysaccharide peaks were collected and combined, and the eluate was placed in a dialysis bag with a molecular weight of 100 Da. It was dialyzed with 10 times the volume of distilled water for 1 day, with the water changed every 3 hours. The extract was then freeze-dried to obtain Polygonatum cyrtonema polysaccharide PF (32.1 g).
[0050] Example 2: Preparation of Polygonatum sibiricum Processed with Coix Seed and Its Extract
[0051] The specific steps are as follows:
[0052] 1) Preparation of Polygonatum cyrtonema prepared from Coix seeds:
[0053] A) 5 kg fresh Polygonatum cyrtonema, clean and slice;
[0054] B) drying the Polygonatum sibiricum tablets at 40°C to a moisture content of 30%;
[0055] C) Dissolve 0.5g of coix seed in 50g of water and decoct the juice, then spray evenly on the large-leafed polygonatum to allow it to fully absorb;
[0056] D) Then place it in a steaming container and steam for 30 hours (100°C);
[0057] E), drying and dehydrating the steamed Polygonatum cyrtonema at 80° C. to a moisture content of 30%, to obtain Coix seed processed Polygonatum cyrtonema.
[0058] 2) Crude extraction (extract I): Take the coix seed processed Polygonatum cyrtonema from step 1), dry it at 40°C to a moisture content of 10%, grind it through a 2-mesh sieve, take 1000g of the processed Polygonatum cyrtonema powder, reflux extract it with 5 times the amount of distilled water for 1h, and filter it; extract it three times in a row; combine the extracts, and concentrate them to dryness under reduced pressure to obtain extract I (765g), with a PF content of more than 5%;
[0059] 3) Decolorization (Extract II): Extract I (765 g) was dissolved in 10 times the volume (V / W) of distilled water, 76.5 g of activated carbon (1%) was added, and the mixture was stirred and decolorized at 40°C for 60 minutes. The mixture was filtered to obtain Extract II (605 g) with a PF content of more than 7%.
[0060] 4) Preparation of Extract III: 403 g of Extract II was dissolved in 1000 mL of distilled water, dialyzed using a dialysis bag with a molecular weight of 200, the solution in the dialysis bag was collected, and then freeze-dried to obtain Extract III (62 g) with a PF content of more than 50%.
[0061] 5) Preparation of Polygonatum cyrtonema polysaccharide (PF): Extract III was dissolved in 2 mmol / L Tris-HCl buffer solution with a pH value of 7.2, and then loaded onto a Sephadex G-25 chromatography column placed in a 4°C chromatography cabinet and eluted with 2.0 mmol / L Tris-HCl buffer solution. The flow rate during elution was controlled at 0.5 mL / min, and 10 mL of eluate was collected in each tube. Sugars were then detected tube by tube at 490 nm using the sulfuric acid-anthrone method. The tubes with the highest polysaccharide peaks were collected and combined to obtain 4 eluate peaks. The eluate 4 was loaded into a dialysis bag with a molecular weight of 100 Da, and dialyzed with 10 times the volume of distilled water for 1 day. The water was changed every 3 hours, and then freeze-dried to obtain Polygonatum cyrtonema polysaccharide PF (32.4 g).
[0062] Example 3: Preparation of Polygonatum sibiricum processed from Coix seeds and its extract
[0063] The specific steps are as follows:
[0064] 1) Preparation of Polygonatum cyrtonema prepared from Coix seeds:
[0065] A) 5 kg fresh Polygonatum cyrtonema, clean and slice;
[0066] B) drying the Polygonatum sibiricum tablets at 60°C to a moisture content of 50%;
[0067] C) Dissolve 25g of coix seed in 250g of water and decoct the juice, then evenly spray it on the Polygonatum sibiricum slices to allow them to fully absorb;
[0068] D) and then steam in a steaming container for 15 hours;
[0069] E), drying and dehydrating the steamed polygonatum at 60° C. to a moisture content of 50%, to obtain coix seed processed polygonatum.
[0070] 2) Crude extraction (Extract I): Take the processed Polygonatum sibiricum from coix seeds in step 1), dry it at 40°C to a moisture content of 10%, grind it through a 2-mesh sieve, take 1000g of the processed Polygonatum sibiricum powder, reflux extract it with 7 times the amount of distilled water for 1h, and filter it; extract it three times in a row; combine the extracts, and concentrate them to dryness under reduced pressure to obtain Extract I (768g) with a PF content of more than 5%.
[0071] 3) Decolorization (Extract II): Extract I (768 g) was dissolved in 10 times the volume (V / W) of distilled water, 7.6 g of activated carbon (0.1%) was added, and the mixture was stirred and decolorized at 70°C for 30 minutes. The mixture was filtered to obtain Extract II (606 g) with a PF content of more than 7%.
[0072] 4) Preparation of Extract III: 405 g of Extract II was dissolved in 1000 mL of distilled water, dialyzed using a dialysis bag with a molecular weight of 200, the solution in the dialysis bag was collected, and then freeze-dried to obtain Extract III (66 g) with a PF content of more than 50%.
[0073] 5) Preparation of Polygonatum cyrtonema polysaccharide (PF): Extract III was dissolved in 2mmol / L Tris-HCl buffer solution with a pH value of 7.2, and then loaded onto a Sephadex G-25 chromatography column placed in a 4°C chromatography cabinet and eluted with 2.0mmol / L Tris-HCl buffer solution. The flow rate was controlled at 0.5mL / min during elution, and 10mL of eluate was collected in each tube. Sugars were then detected tube by tube at 490nm using the sulfuric acid-anthrone method. The tubes with the highest polysaccharide peaks were collected and combined to obtain 4 eluate peaks. The eluate 4 was loaded into a dialysis bag with a molecular weight of 100Da, and dialyzed with 10 times the volume of distilled water for 1d. The water was changed every 3h, and then freeze-dried to obtain Polygonatum cyrtonema polysaccharide PF (33.1g).
[0074] Comparative Example 1: Preparation of Polygonatum cyrtonema extract
[0075] 1) Polygonatum cyrtonema: fresh Polygonatum cyrtonema, dried at 60℃.
[0076] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (0.1 g).
[0077] Comparative Example 2: Preparation of nine-steamed and nine-processed polygonatum and its extract
[0078] 1) Preparation of nine-steamed and nine-processed large-leaf polygonatum (Dietary Materia Medica): 1000 g of large-leaf polygonatum slices were adjusted to have a moisture content of 50%; steamed nine times according to traditional technology (each time for 1.5 hours, at a temperature of 100° C., for a total of 14.5 hours), and "dried" nine times (each time for one day); finally, the moisture content was adjusted to about 50% to obtain nine-steamed and nine-processed polygonatum (the moisture content was higher than that of traditional nine-steamed and nine-processed polygonatum).
[0079] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (13.3 g).
[0080] Comparative Example 3: Preparation of wine-processed polygonatum and its extract
[0081] 1) Preparation of wine-processed Polygonatum cyrtonema (Chinese Pharmacopoeia): 1000 g of Polygonatum cyrtonema slices and 200 g of yellow rice wine were used to prepare the wine-processed Polygonatum cyrtonema according to the pharmacopoeia method.
[0082] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (12.8 g).
[0083] Comparative Example 4: Preparation of Polygonatum sibiricum prepared from black beans and its extract
[0084] 1) Preparation of large-leaf polygonatum prepared from black beans (Huoren Shizheng Fangji): 1000g of large-leaf polygonatum slices, adjusting the water content to 50%; 100g of black beans, decocting the juice, and evenly stirring the juice into the polygonatum slices for full absorption; then steaming nine times according to traditional technology (each time for 1.5 hours, temperature 100°C, a total of 14.5 hours of steaming), and "drying" nine times (each time for one day); finally adjusting the water content to about 50% to obtain nine-steamed and nine-dried polygonatum (the water content is higher than that of traditional nine-steamed and nine-dried polygonatum).
[0085] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (12.3 g).
[0086] Comparative Example 5: Patented technology (202111097157.7) Preparation of Polygonatum sibiricum and its extract
[0087] 1) Processing (202111097157.7): Remove impurities and fibrous roots from fresh polygonatum, wash, slice, and place at 10-100°C to dehydrate until the water content of the polygonatum is 80-30%; place the partially dehydrated polygonatum in a steaming container and steam for 15-25 hours until it is cooked through and then take it out; dry the steamed polygonatum at 50-80°C to make its moisture content less than 5%, thereby obtaining processed polygonatum.
[0088] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (12.7 g).
[0089] Comparative Example 6: Preparation of Polygonatum cyrtonema-Job's tears complex and extract thereof
[0090] 1) Polygonatum cyrtonema-Job's tears complex: 5 kg of fresh Polygonatum cyrtonema-Job's tears were cleaned and sliced; the Polygonatum cyrtonema slices were dried and dehydrated at 60° C. to a moisture content of 50%; 25 g of Job's tears were dissolved in 250 g of water to make a decoction, and the Polygonatum cyrtonema-Job's tears juice was dried and dehydrated at 60° C. to a moisture content of 50% to obtain a Polygonatum cyrtonema-Job's tears complex.
[0091] 2) Extraction: Preparation of Polygonatum cyrtonema polysaccharide: The same method as in Example 3 was used to obtain Polygonatum cyrtonema polysaccharide (0.01 g).
[0092] Test Example 1: PF molecular weight and molecular composition analysis
[0093] 1. Experimental Materials
[0094] Polygonatum cyrtonema polysaccharide PF prepared under the conditions of Example 3.
[0095] 2. Experimental methods and results
[0096] Determination of PF purity: Sephadex G-50 column separation yields a single peak ( Figure 1 ); The result of GPC experimental analysis is also a single peak ( Figure 2 ), indicating that the obtained PF is pure. The molecular weight of PF is: Mn=638, Mw=762, Mz=987, that is, the mass is between 638-987. Figure 2 shown.
[0097] Determination of PF molecular weight: PF was analyzed by high-resolution biomass spectrometry, and the molecular weight of its typical molecule was 828. Figure 3 shown.
[0098] Determination of PF molecular structure: Using gas chromatography ( Figure 4 )、H Spectrum( Figure 5 )、Carbon Spectrum( Figure 6 ), methylation followed by gas chromatography-mass spectrometry ( Figure 7 ) and other comprehensive spectral analyses, and finally determined that the typical representative molecule of PF (a polysaccharide molecule with a molecular weight of 828) is a polyfructose derivative composed of 2 β-pyranose, 2 β-furanose, and 1 α-furanose. Figure 8 shown.
[0099] Experimental Example 2: Study on the effects of different processing methods on the stimulating substances of Polygonatum cyrtonema
[0100] 1. Test materials:
[0101] Test drug 1: Polygonatum cyrtonema prepared from coix seeds according to the conditions of Example 3.
[0102] Control drug 1: Polygonatum cyrtonema prepared according to Comparative Example 1.
[0103] Control drug 2: prepared Polygonatum cyrtonema (wine-processed Polygonatum cyrtonema) prepared according to Comparative Example 2.
[0104] Control drug 3: processed Polygonatum cyrtonema (nine-steamed and nine-processed Polygonatum cyrtonema) prepared according to Comparative Example 3.
[0105] Control drug 4: prepared Polygonatum cyrtonema (prepared Polygonatum cyrtonema with black beans) prepared according to Comparative Example 4.
[0106] Control drug 5: Prepared Polygonatum sibiricum prepared according to comparative example 5 (prepared Polygonatum sibiricum with patent technology (202111097157.7)).
[0107] Control drug 6: prepared Polygonatum sibiricum (complex of Polygonatum sibiricum and Coix seeds) prepared according to Comparative Example 6.
[0108] 2. Experimental methods
[0109] Tasting of numbness and stimulating smell: Feel the "numbing taste" of the sample and my "stimulating taste" by tasting with the tongue and sniffing with the nose.
[0110] Gas chromatography was used to detect the changes in the contents of n-hexanal and D-camphor in the samples. The relevant results are shown in Table 1
[0111] Table 1. Study on the effects of different processing techniques on the side effects of Polygonatum odoratum and its components
[0112]
[0113] Raw Polygonatum sibiricum (unprocessed Polygonatum sibiricum) has a "numbing smell" and "pungent smell". The research results show that this is related to the volatile components contained in Polygonatum sibiricum. Among these volatile components, "aldehydes" and "ketones" are its main odor and toxic and side effect components, and typical representatives are n-hexanal and D-camphor (Wang Jin et al., Chinese Journal of Traditional Chinese Medicine, 2011). This study tasted the "numbing smell" and "irritating taste" through the senses of "tasting with the tongue" and "smelling with the nose". The changes in the content of n-hexanal and D-camphor in the samples and the processing technology were detected by gas chromatography. The results are shown in Table 1. The results show that the raw Polygonatum sibiricum has a heavier "numbing smell" and "irritating taste", and the content of n-hexanal and D-camphor is very high (control drug 1); after steaming, the "numbing smell" and "irritating taste" are reduced, and the content of n-hexanal and D-camphor is significantly reduced. Comparing the processing of coix seeds with the traditional processing method, it can be found that: after the processing of coix seeds, as the steaming time increases, the "numbing taste" and "irritating taste" disappear quickly, and disappear after 10 hours of steaming. The content of n-hexanal and D-camphor also decreases rapidly, and almost completely disappears after 15 hours of steaming (Test Example 1); with the traditional processing method (nine steaming and nine drying, wine processing and black bean processing), as the steaming time increases, the "numbing taste" and "irritating taste" also decrease, but the rate of decrease is slow, and the taste and smell disappear after 20 hours of steaming, while the rate of decrease of n-hexanal and D-camphor is slow, especially after 20 hours, and even if it is steamed for 30 hours, it still contains There is a certain amount of n-hexanal and D-camphor (Comparative Examples 2-4); the processed polygonatum obtained by the patented processing technology (202111097157.7) has a "numbing taste" and "irritating taste" as the steaming time increases. The numbness and irritation disappear when steaming for 20 hours, while n-hexanal and D-camphor still have a certain amount, even if steamed for 30 hours, they still contain a certain amount of n-hexanal and D-camphor (Comparative Example 5); if coix seed extract is added to large-leaf polygonatum, if it is not steamed, the "numbing taste" and "irritating taste" are very strong, and the content of n-hexanal and D-camphor is not much different from that of raw polygonatum without coix seed (Comparative Example 6). It can be seen that the improvement of taste, smell and safety evaluation of coix seed processed polygonatum is obvious (see Table 1 and Table 2).
[0114] Test Example 3: Safety Study of Processed Polygonatum cyrtonema
[0115] 1. Test materials
[0116] Test drug 1: Polygonatum cyrtonema prepared from coix seeds according to the conditions of Example 3;
[0117] Control drug 1: Polygonatum cyrtonema prepared according to Comparative Example 1;
[0118] Control drug 2: prepared Polygonatum cyrtonema (wine-processed Polygonatum cyrtonema) prepared according to Comparative Example 2.
[0119] Control drug 3: processed Polygonatum cyrtonema (nine-steamed and nine-processed Polygonatum cyrtonema) prepared according to Comparative Example 3.
[0120] Control drug 4: prepared Polygonatum cyrtonema (prepared Polygonatum cyrtonema with black beans) prepared according to Comparative Example 4.
[0121] Control drug 5: Prepared Polygonatum sibiricum prepared according to comparative example 5 (prepared Polygonatum sibiricum with patent technology (202111097157.7)).
[0122] Control drug 6: prepared Polygonatum sibiricum (complex of Polygonatum sibiricum and Coix seeds) prepared according to Comparative Example 6.
[0123] 2. Experimental methods
[0124] Test method (according to the national new drug application test method): 80 Kunming mice, half male and half female, were randomly divided into eight groups; after balanced feeding for 6 days, they were set aside; the drug was crushed through 150 mesh and prepared into a 20% solution for intragastric administration: the mice were intragastrically administered three times a day (0.8 mL each time), with an interval of 8 hours between each administration; the control group was intragastrically administered with the same volume of distilled water. The toxic reactions and deaths of the animals were observed and recorded once in the morning every day, and the weight gain was recorded after the drug was administered every day; the animals were killed on d14, and the tissues and organs were observed with the naked eye. For those with obvious lesions, relevant tissues were taken for pathological examination.
[0125] The results showed that the mice were gavaged with the drug three times within 24 hours, with the highest dose reaching 24g / kg. No mice died and there was no significant change in their activity. Within 3 days after gavage, the weight of the mice was slightly lower than that of the normal group. After 5 days, the weight of the two groups of mice tended to be the same; after 14 days of feeding, no abnormalities were found in the autopsy of the mice. Regarding the diarrhea of mice: in the unprocessed large-leaf Polygonatum group, 8 mice had diarrhea, which was related to the large side effects of raw Polygonatum (Comparative Example 1); none of the large-leaf Polygonatum processed with coix seeds had diarrhea, which may be because coix seeds itself is cool in nature, eliminating the "heat" that occurs during the steaming process of Polygonatum. Coix seeds have the effects of "diuresis, invigorating the spleen and stopping diarrhea" (Chinese Pharmacopoeia), which overcomes the "diarrhea" effect caused by steaming Polygonatum (Test Example 1). At the same time, the co-steaming process of coix seeds and Polygonatum promotes the production of new Polygonatum polysaccharides (PF), which has a positive effect on mild abdominal distension or diarrhea in Polygonatum. Adverse reactions may play a certain role; 2, 1, and 1 diarrhea occurred in the nine-steamed and nine-processed large-leaf Polygonatum, wine-processed, and black bean-processed large-leaf Polygonatum, respectively, indicating that the side effects of Polygonatum can also be reduced, but the effect is not as obvious as coix seed; Patented technology (202111097157.7) processed large-leaf Polygonatum, only 1 diarrhea, indicating that the side effects of Polygonatum can also be reduced, but its effect is not as obvious as coix seed (Comparative Example 5); Large-leaf Polygonatum and corn complex, 8 diarrhea, indicating that the direct compound of the two without processing, did not eliminate the side effects of Polygonatum (Comparative Example 6). It can be seen that the large-leaf Polygonatum processed by this process is safer.
[0126] Table 2 Results of body weight and diarrhea experiments on mice after oral administration of Polygonatum sibiricum products
[0127]
[0128] Experimental Example 4: Analysis of Polygonatum cyrtonema extracts and their polysaccharide contents from different processing techniques
[0129] According to the methods of Examples 1-3 and Comparative Examples 1-6, extracts I, II, III and Polygonatum cyrtonema polysaccharide (PF) were prepared. The experimental parameters are shown in Table 3.
[0130] As can be seen from Table 3, the extracts I, extracts II, extracts III and polygonatum polysaccharide (PF) prepared in Examples 1-3 are not much different, and the content of polygonatum polysaccharide (PF) does not change much. The extracts I prepared by other different methods are quite different: the extract I of unprocessed polygonatum is significantly less (Comparative Example 1); after processing, the amount of extract I increases significantly, and the extracts I obtained by nine steaming and nine drying and wine are slightly lower than the extracts obtained by coix seed, but the difference is not big (Comparative Examples 2 and 3); the extract I obtained by black bean is the most (Comparative Example 4); this may be related to the fact that extract I is a full extract, as long as all water-soluble substances are extracted, the more water-soluble components, the more extract I; the extract I obtained by patent technology (202111097157.7) is not much different from the traditional nine steaming and nine processing polygonatum extract I (Comparative Example 5); the extract I obtained by the complex of polygonatum and coix seed is not much different from the extract I of unprocessed polygonatum (Comparative Example 6). It can be seen that the water-soluble components vary greatly due to different processing methods.
[0131] The extracts II obtained by different processing methods are not much different: the extract II of unprocessed Polygonatum is significantly less (Comparative Example 1); the amount of extract II does not change much with other processing methods (Examples 1-3 and Comparative Examples 2-3), except that the black bean process is slightly more (Comparative Example 4); the extract II obtained by the patented technology (202111097157.7) is not much different from the traditional nine-steamed and nine-processed Polygonatum (Comparative Example 5); the extract II obtained by the complex of Polygonatum and Coix seeds is not much different from the extract II of unprocessed Polygonatum (Comparative Example 6). Extract II mainly includes water-soluble components such as polysaccharides, and the slightly more black bean extract may be related to the high protein content. It can be seen that the "total polysaccharides" and "total protein" obtained by various processing methods do not change much.
[0132] The extracts III obtained by different methods are obviously different: the extract III of unprocessed Polygonatum is significantly less (Comparative Example 1); although the extracts I and II of Polygonatum processed with black beans are the most, the extract III is indeed significantly reduced (Comparative Example 4), even less than the nine-steaming and nine-drying and wine-processed ones (Comparative Examples 2 and 3); the extract III obtained by the patented technology (202111097157.7) is not much different from the traditional nine-steaming and nine-processing Polygonatum (Comparative Example 5); the extract III obtained by the complex of Polygonatum and coix seed is not much different from the extract III of unprocessed Polygonatum (Comparative Example 6). Overall, the extract III of Polygonatum processed with coix seed is significantly higher than that of other processing methods (Examples 1-3 and Comparative Examples 2-6). Extract III is a component with a "molecular weight between 200--5000", and small molecules such as monosaccharides and ultra-large molecules are separated by dialysis.
[0133] After extract III was chromatographed on Sephadex G-25, the difference in the amount of PF obtained was very significant: the large-leaf Polygonatum before processing contained almost no PF (Comparative Example 1); the amount of PF in the large-leaf Polygonatum after nine steaming and nine drying, wine processing and black bean processing increased significantly (Comparative Examples 2-4); the PF obtained by the patented technology (202111097157.7) was not much different from the PF of the traditional nine-steaming and nine-processing Polygonatum (Comparative Example 5); the PF obtained by the complex of Polygonatum and coix seed was not much different from the PF of unprocessed Polygonatum (Comparative Example 6), and almost no PF was contained; the content of PF in the large-leaf Polygonatum processed with coix seed was further significantly increased (Test Example 1). The study found that PF was converted from other components in the process of large-leaf Polygonatum with coix seed processing (the research paper has not yet been published). In fact, the changes in taste and various properties during the processing of Polygonatum sibiricum are related to the changes in its chemical composition (Dong Baohua et al., The evolution of the processing of large-leaf Polygonatum sibiricum and modern research progress, Chinese Journal of Traditional Chinese Medicine, V20(11): 213, 2022); what kind of changes will be shown by different processing methods needs to be determined through specific experiments.
[0134] The experimental results also show that as the steaming time increases, the amount of PF in Polygonatum increases, especially in the first 10 hours, the increase in PF is very obvious (comparison between Comparative Example 1 and Example 1); when the steaming time exceeds 30 hours, the content of PF tends to decrease slightly (comparison between Examples 1, 2, and 3, etc.). Therefore, the steaming time is preferably 10-30 hours.
[0135] Table 3 Effect of different processing techniques on the yield of Polygonatum sibiricum polysaccharide
[0136]
[0137] Test Example 5: Experiment on the effect of Polygonatum cyrtonema extract on enhancing memory and preventing Alzheimer's disease
[0138] 1. Experimental Materials
[0139] Test drug 1: Extract I prepared according to the conditions of Example 3.
[0140] Test drug 2: Extract II prepared according to the conditions of Example 3.
[0141] Test drug 3: Extract III prepared according to the conditions of Example 3.
[0142] Test drug 4: PF prepared according to the conditions of Example 3.
[0143] Control drug 1: Polygonatum cyrtonema polysaccharide prepared according to patented technology (application number 202210621078.X).
[0144] Control drug 2: Unsteamed fresh Polygonatum cyrtonema raw material, extract I prepared according to Comparative Example 1.
[0145] Control drug 3: wine-processed Polygonatum cyrtonema, extract I prepared according to comparative example 1.
[0146] Control drug 4: Extract I of nine-steamed and nine-processed Polygonatum cyrtonema, prepared according to Comparative Example 1.
[0147] Control drug 5: Extract I of Polygonatum cyrtonema prepared from black beans, prepared according to Comparative Example 1.
[0148] Control drug 6: Polygonatum sibiricum and Coix seeds complex, extract I prepared according to Comparative Example 1.
[0149] Experimental animals: 130 male 6-week-old SPF-grade KM mice, weighing 27-29 g, were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd. All mice were raised in an environment with a temperature of (22±1)°C, relative humidity of 40%-60%, and a light intensity of 12h / 12h alternating light and dark.
[0150] 2. Stir the drug thoroughly until it is completely dissolved and store it in a refrigerator at 4°C. KM mice were allowed to drink water and eat freely every day. After one week of adaptive feeding, they were randomly divided into 13 groups, with 10 mice in each group, namely blank group, model group, Polygonatum cyrtonema extract I group (1700 mg / Kg), Polygonatum cyrtonema extract II group (1360 mg / Kg), Polygonatum cyrtonema extract III group (136 mg / Kg), PF group (70 mg / Kg), control group 1 (70 mg / Kg), control drug 2 (1700 mg / Kg), control drug 3 (1700 mg / Kg), control drug 4 (1700 mg / Kg), control drug 5 (1700 mg / Kg), and control drug 6 (1700 mg / Kg).
[0151] 3. The KM mice in the model group and the drug group were intraperitoneally injected with D-gal (150 mg / kg) every day, and the blank group was intraperitoneally injected with an equal amount of saline for 1 week; after 1 week, the drug group was gavaged with drugs every afternoon at a fixed time period between 16:00 and 17:00, and the blank group and the model group were gavaged with an equal volume of saline, and the drugs were continuously administered for 10 weeks. In the fourth week of modeling, the mouse novel object recognition experiment was used to detect whether the D-gal-induced cognitive dysfunction model was successful (based on whether the discrimination index decreased significantly). The body weight of KM mice was weighed and recorded every week.
[0152] 4. Morris water maze experiment: Morris water maze was used to test the spatial memory ability of KM mice, including positioning navigation, spatial exploration and counterpoint exploration experiments. The body of the Morris water maze is a circular pool with a diameter of 120 cm and a height of 50 cm. The water tank is about 40 cm high. The pool is divided into four quadrants in the east, west, south and north directions, named I, II, III, and IV quadrants respectively, and four water entry points (southeast point, northeast point, northwest point, southwest point) are set in sequence. The platform is circular, with a diameter of 10 cm and a height of about 30 cm. It is placed under the water surface. The surface of the platform is designed to be rough so that KM mice can stand firmly and maintain it for about 10 seconds. The water temperature was maintained at (25±1)℃ during the experiment. Since KM mice are white, edible ink was used to dye the pool black so that the video system could track the swimming trajectory of KM mice in real time. The experimental environment was kept quiet throughout the whole process, and the design of the reference objects all met the experimental standards and remained stable. The experimental process was completed by the same experimenter as much as possible to reduce unnecessary errors caused by the experimenter.
[0153] 5. The 4 days before the experiment are the adaptation period training. Randomly select a point in a quadrant on the pool wall, gently support the KM mouse, grab the back and tail to prevent the KM mouse from being frightened and producing stress behavior, make the KM mouse face the pool wall of the Morris water maze as a whole, slowly put the KM mouse into the water, and observe the movement of the KM mouse in the dark. The experimenter should stay out of the sight of the KM mouse to avoid affecting the swimming speed and range of the KM mouse. If the platform cannot be found within 60 seconds, use a fishing net to guide the KM mouse to find the platform, and ensure that the KM mouse stays on the platform for 10 seconds. Repeat four times a day, and randomly put it in from different quadrants each time. After the training of each KM mouse, carefully wipe the water droplets on the hair with a cloth, put it in the breeding cage, and train the next KM mouse.
[0154] 6. On the fifth day of the experiment, a spatial exploration experiment was conducted to evaluate the spatial memory ability of mice. The platform was removed, and other conditions remained unchanged. KM mice were placed at random water entry points, and the number of times the KM mice crossed the platform quadrants and the time they stayed in the target quadrant within 60 seconds were recorded in detail. This experiment was repeated twice by placing mice at random points (quadrants I and III, or quadrants II and IV, could be selected).
[0155] 7. Days 6 to 8 are for counterposition training. The platform is placed on the opposite side of the original quadrant (diagonally opposite the position during acquisition training). A fixed point on the pool wall is randomly selected, and the KM mice are gently lifted so that they are placed into the pool facing the pool wall. Training is conducted 4 times a day. Each time, the mice are placed into the water from a random entry point in turn to guide them to find the platform and ensure that they stay on the platform for 10 seconds.
[0156] On the 8th and 9th days, the position exploration experiment was carried out to evaluate the learning and memory ability of KM mice. The platform was removed and the other experimental conditions remained unchanged. The experiment was carried out twice.
[0157] 9. After the experiment, the eyeballs of KM mice were removed to collect blood, and the mice were killed by dislocating the neck. The brain tissue was quickly removed and divided into two halves from the longitudinal fissure of the brain. One half was fixed in 4% paraformaldehyde for subsequent histopathological examination. (1) Paraffin section: The fixed mouse hippocampal tissue was embedded in paraffin and cut into 4 μm slices. (2) Dewaxing to water: The slices were placed in xylene I for 20 min-xylene II for 20 min-anhydrous ethanol I for 5 min-anhydrous ethanol II for 5 min-75% alcohol for 5 min, and then washed with tap water. (3) Staining: First, the cell nuclei were stained with hematoxylin solution, then differentiated with 1% hydrochloric acid ethanol solution, and then stained with eosin staining solution after blueing treatment with blueing solution. After washing with tap water, the slices were placed in an oven to dry. (4) Transparent sealing: The slices were placed in clean xylene for 5 min and sealed with neutral gum. (5) Microscopic examination: Observe and collect images under a microscope and analyze the results.
[0158] 10. Experimental Results
[0159] The results of Morris water maze test are shown in Table 4:
[0160] Table 4 Results of Morris water maze test in mice
[0161]
[0162]
[0163] Note: Compared with the blank group, #P<0.05; compared with the model group, *P<0.05, **P<0.01; compared with the control drug, Δ P<0.05.
[0164] The experimental results in Table 4 show that the number of crossings and the duration of stay in the target quadrant in the model group were significantly reduced (P < 0.05), indicating that the model was successfully established. Compared with the model group, each drug group can significantly increase the number of crossings and the duration of stay in the model mice, indicating that they can enhance the learning ability of mice.
[0165] Polygonatum sibiricum polysaccharide (PF) has a strong ability to improve the memory of experimental mice, which can reach an extremely significant level (P < 0.01). Although Polygonatum sibiricum polysaccharide (patent technology, application number 202210621078.X) can significantly improve the memory ability of experimental mice, reaching a significant level (P < 0.05); but compared with Polygonatum sibiricum polysaccharide (patent technology, application number 202210621078.X), processed Polygonatum sibiricum polysaccharide (PF) is significantly better than Polygonatum sibiricum polysaccharide (P < 0.05).
[0166] Compared with extracts I, II, III and PF, although the amount of PF is the same, extract I has the best effect and is significantly better than extracts II, III and PF. This may be related to the fact that extract I contains, in addition to PF, "other processed Polygonatum sibiricum polysaccharides" and other effective ingredients for enhancing memory; similarly, extract II is better than extract III and PF, and extract III is better than PF, which may be related to the fact that extracts I, II and III contain, in addition to PF, other effective ingredients.
[0167] The memory-enhancing effect of the polygonatum extract I obtained by this process is significantly improved compared with the extract I obtained by the traditional processing process (compared with the test drug 1 and the control drugs 3-6), which may be related to the high PF content obtained by this process; the effect of the polygonatum and coix seed complex is the same as that of the unprocessed polygonatum (control drug 2 and control drug 6).
[0168] Test Example 6: Experiment on hypoglycemic activity of Polygonatum cyrtonema extract
[0169] 1. Experimental Materials
[0170] Test drug 1: Extract I prepared according to the conditions of Example 3.
[0171] Test drug 2: Extract II prepared according to the conditions of Example 3.
[0172] Test drug 3: Extract III prepared according to the conditions of Example 3.
[0173] Test drug 4: PF prepared according to the conditions of Example 3.
[0174] Control drug 1: Polygonatum cyrtonema polysaccharide prepared according to patent technology (application number 202210621078.X);
[0175] Control drug 2: fresh Polygonatum cyrtonema raw material without steaming, and extract I prepared according to Example 4.
[0176] Control drug 3: wine-processed Polygonatum cyrtonema, extract I prepared according to comparative example 1.
[0177] Control drug 4: Extract I of nine-steamed and nine-processed Polygonatum cyrtonema, prepared according to Comparative Example 1.
[0178] Control drug 5: Extract I of Polygonatum cyrtonema prepared from black beans, prepared according to Comparative Example 1.
[0179] Control drug 6: Polygonatum sibiricum and Coix seeds complex, extract I prepared according to Comparative Example 1.
[0180] 2. Experimental methods
[0181] Glucose consumption experiment in cells: Digested and diluted HepG2 cells were added to a 96-well plate. When the cell confluence rate reached 80%, the original culture medium was replaced, and the cells were washed once with PBS buffer. 250 μL of culture medium containing or without drugs was added to each well. The blank group and each experimental group were repeated three times. After 24 hours, the remaining amount of glucose in the culture medium was detected at a wavelength of 505 nm using an enzymatic method. The glucose consumption of each group was obtained by subtracting the residual amount of glucose in the blank from the control and each treatment group, expressed as GC. In order to consider the effect of cell proliferation, the final result of glucose consumption was expressed as GC / MTT.
[0182] 3. Experimental results
[0183] Table 5 Experimental results of drugs promoting HepG2 cells to consume glucose
[0184]
[0185] Note: Compared with the blank group, *P<0.05, **P<0.01; compared with the control drug 1, Δ P<0.05; compared with control drug 2,
[0186] The experimental results in Table 5 show that compared with the blank group, the GC / MTT of each drug group has increased. When the test drug 1 reaches a medium concentration, the GC / MTT ratio has increased significantly (*P < 0.05), and it reaches a very significant level at a high concentration (**P < 0.01), indicating that the test drug has a good hypoglycemic effect (test drug 1); with the increase of PF concentration, the hypoglycemic ability continues to increase, and PF has the strongest hypoglycemic ability (comparison test drug 1, test drug 2, test drug 3, PF); compared with the large-leaf Polygonatum sibiricum polysaccharide extracted by the patented technology, the large-leaf Polygonatum sibiricum polysaccharide PF extracted by this extraction has a significantly better hypoglycemic effect than the polysaccharide of the patented technology (ΔP < 0.05); compared with the unprocessed Polygonatum sibiricum extract, the hypoglycemic effect after processing is significantly enhanced Compared with the large-leaf Polygonatum processed by the traditional process, the large-leaf Polygonatum obtained by the present processing technology has a better hypoglycemic effect than the process technology, but it does not reach a significant level (comparison between the test case and the control group 3-6); the complex of Polygonatum and Coix seeds has the same effect as the unprocessed Polygonatum (control drug 2 and control drug 6). It can be seen that after processing using this process technology, the hypoglycemic activity is significantly improved.
[0187] Test Example 7: Antioxidant Activity Test of Polygonatum cyrtonema Extract
[0188] 1. Experimental Materials
[0189] Test drug 1: Extract I prepared according to the conditions of Example 3.
[0190] Test drug 2: Extract II prepared according to the conditions of Example 3.
[0191] Test drug 3: Extract III prepared according to the conditions of Example 3.
[0192] Test drug 4: PF prepared according to the conditions of Example 3.
[0193] Control drug 1: Polygonatum cyrtonema polysaccharide prepared according to patent technology (application number 202210621078.X);
[0194] Control drug 2: fresh Polygonatum cyrtonema raw material without steaming, and extract I prepared according to Example 4.
[0195] Control drug 3: wine-processed Polygonatum cyrtonema, extract I prepared according to comparative example 1.
[0196] Control drug 4: Extract I of nine-steamed and nine-processed Polygonatum cyrtonema, prepared according to Comparative Example 1.
[0197] Control drug 5: Extract I of Polygonatum cyrtonema prepared from black beans, prepared according to Comparative Example 1.
[0198] Control drug 6: Polygonatum sibiricum and Coix seeds complex, extract I prepared according to Comparative Example 1.
[0199] 2. Experimental methods
[0200] (1) A549 cell culture and MTT assay: 1 ml of frozen cells were taken out of the liquid nitrogen tank and thawed quickly in a 37°C water bath. The revived cell solution was then transferred to a 10 ml centrifuge tube on a clean bench, 4 ml of cell culture medium was added, and the tube was centrifuged at 3000 rpm for 10 minutes. The supernatant was discarded, 3 ml of cell culture medium was added again, and the tube was transferred to a cell culture bottle and cultured in an incubator containing 5% CO2 at 37°C. The basic culture medium for A549 cells was DMEM (containing 10% FBS and 1% penicillin-streptomycin).
[0201] (2) ROS scavenging experiment in cells: First, cells were seeded onto 48-well plates, and monolayer cells were allowed to adhere for 24 h. Cells were treated with AAPH at concentrations of 0, 1, 10, 50, and 100 μg / ml for 2, 4, 6, and 8 h, respectively. Three replicate wells were set for each concentration. After treatment, fresh serum-free culture medium was added with 2 μl of 5 mmol / L DCFH-DA for 1 h (37°C, 5% CO 2). Then, residual DCFH-DA was washed away with PBS, and 50 μL of cell lysis buffer was added for 30 seconds. Cells were resuspended in 800 μL of buffer PBS, and detected and photographed on a fluorescence spectrophotometer with an excitation wavelength of 485 nm and an emission wavelength of 530 nm.
[0202] After determining the optimal modeling concentration and time of AAPH, the ability of drugs to scavenge ROS is compared based on this model. The specific operation is: after the cells adhere to the wall, add 150μL of serum-free culture and 1, 5, 25μg / ml (concentrations screened by MTT) of drugs for co-culture for 1h, then add AAPH for co-treatment, remove the culture medium containing AAPH and replace it with fresh serum-free culture medium and continue to culture for 16h, with 3 replicates for each concentration and 2 parallels. Finally, add 2μl of fluorescent probe 5mmol / LDCFH-DA and incubate for 1h (37℃, 5% CO 2), wash away the residual DCFH-DA with PBS, add 50μL of cell lysis solution and measure the fluorescence value after lysis. This experiment also has a blank group, a model group, and a drug group. The blank group does not add drugs and AAPH, and the model group does not add drugs. Other operations are the same.
[0203] 3. Experimental results
[0204] Table 6 Results of drug removal of intracellular peroxides
[0205]
[0206] Note: Compared with the blank group, #P<0.01; compared with the model group, *P<0.05, **P<0.01; compared with the control drug 1, Δ P<0.05; compared with control drug 2,
[0207] The increase of peroxides in the body is an important cause of aging. Eliminating peroxides in the body has an anti-aging effect. The experimental results in Table 6 show that the peroxides (ROS) in the model group were significantly higher than those in the blank group (##P<0.01), indicating that the model was successfully established. Compared with the model group, the ROS values of each drug group decreased; although the unprocessed large-leaf Polygonatum decreased, it did not reach a significant level until 25μg / mL, indicating that the antioxidant effect was not obvious; the large-leaf Polygonatum processed (steamed) according to this process had a significantly increased antioxidant effect, reaching a significant level at a high dose (*P<0.05); with the increase of PF concentration, the antioxidant capacity continued to increase, and PF had the strongest antioxidant capacity (i.e., the strongest anti-aging capacity) (comparison test drug 1, test drug 2, test drug 3, PF); compared with the large-leaf Polygonatum polysaccharide extracted by the patented technology, the large-leaf Polygonatum glycoprotein PF extracted by this extraction had a significantly better anti-aging effect than the polysaccharide (ΔP<0.05); compared with the unprocessed Polygonatum extract, the hypoglycemic effect after processing was significantly enhanced Compared with the large-leaf Polygonatum prepared by the traditional process, the large-leaf Polygonatum obtained by the present processing technology has a better effect in eliminating peroxides than the process technology, but it has not reached a significant level (comparison between the test case and the control group 3-6); the complex of Polygonatum and Coix seeds has the same effect as the unprocessed large-leaf Polygonatum (control drug 2 and control drug 6). It can be seen that after processing using this process technology, the antioxidant activity is significantly improved.
[0208] After being processed by this process technology, the antioxidant capacity and anti-aging ability of Polygonatum sibiricum are significantly increased; Polygonatum sibiricum glycoprotein PF has a very strong antioxidant effect, which is far superior to the large-leaf Polygonatum sibiricum polysaccharide extracted by patented technology (application number 202210621078.X).
[0209] Test Example 8: Anti-fatigue activity test of Polygonatum cyrtonema extract
[0210] 1. Experimental Materials
[0211] Test drug 1: Extract I prepared according to the conditions of Example 3.
[0212] Test drug 2: Extract II prepared according to the conditions of Example 3.
[0213] Test drug 3: Extract III prepared according to the conditions of Example 3.
[0214] Test drug 4: PF prepared according to the conditions of Example 3.
[0215] Control drug 1: Polygonatum cyrtonema polysaccharide prepared according to patent technology (application number 202210621078.X);
[0216] Control drug 2: fresh Polygonatum cyrtonema raw material without steaming, and extract I prepared according to Example 4.
[0217] Control drug 3: wine-processed Polygonatum cyrtonema, extract I prepared according to comparative example 1.
[0218] Control drug 4: Extract I of nine-steamed and nine-processed Polygonatum cyrtonema, prepared according to Comparative Example 1.
[0219] Control drug 5: Extract I of Polygonatum cyrtonema prepared from black beans, prepared according to Comparative Example 1.
[0220] Control drug 6: Polygonatum sibiricum and Coix seeds complex, extract I prepared according to Comparative Example 1.
[0221] 2. Experimental methods
[0222] Experimental animals: 120 male 6-week-old SPF-grade KM mice, weighing 27-29 g, were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd. All mice were raised in an environment with a temperature of (22±1)°C, relative humidity of 40%-60%, and a light intensity of 12h / 12h alternating light and dark.
[0223] The drug was stirred until completely dissolved and stored in a refrigerator at 4°C. KM mice were allowed to drink water and eat freely every day. After one week of adaptive feeding, they were randomly divided into 12 groups, 10 mice in each group, namely, blank group, Polygonatum cyrtonema extract I group (1700 mg / Kg), Polygonatum cyrtonema extract II group (1360 mg / Kg), Polygonatum cyrtonema extract III group (136 mg / Kg), PF group (70 mg / Kg), control group 1 (70 mg / Kg), control drug 2 (1700 mg / Kg), control drug 3 (1700 mg / Kg), control drug 4 (1700 mg / Kg), control drug 5 (1700 mg / Kg), and control drug 6 (1700 mg / Kg). The drug was administered continuously for 7 days. 30 minutes after the last administration of the test substance, the mice were placed in a swimming box to swim. The water depth was not less than 30 cm and the water temperature was 25°C ± 0.5°C. The base of the mouse tail was loaded with 5% of the body weight of lead. The time from the start of swimming to the death of the mouse was recorded as the mouse swimming time (min). The experimental results are shown in Table 7.
[0224] Table 7 Results of mouse swimming experiment
[0225]
[0226]
[0227] Note: Compared with the blank group, *P<0.05, **P<0.01; compared with the control drug 1, Compared with control drug 2, Δ P<0.05.
[0228] The experimental results in Table 7 show that: compared with the blank control, the Polygonatum sibiricum extract and PF processed by this process have improved anti-fatigue effects (*P < 0.05); Extract I has the best anti-fatigue effect (*P < 0.01), which may be related to the fact that the extract contains other anti-fatigue ingredients in addition to PF; similarly, Extract II and Extract III also have good anti-fatigue effects, both reaching extremely significant levels (*P < 0.01); The anti-fatigue effect of Extract I is due to the fact that Extract II, III and PF contain more abundant other ingredients in the extract (comparison of test drugs 1-3). The anti-fatigue effect of Polygonatum sibiricum processed by this process technology is better than that of the patented technology (test drug 4 and control drug 1, ); The anti-fatigue effect of the extract I obtained by the process technology is significantly better than that of the unprocessed polygonatum extract (test drug 1 and control drug 2, Δ P<0.05); compared with the large-leaf polygonatum processed by traditional technology, the large-leaf polygonatum obtained by this processing technology has better anti-fatigue effect than the process technology, reaching a significant level (compared with the test case and the control group 3-6); the effect of the complex of polygonatum and coix seed is the same as that of the unprocessed large-leaf polygonatum (control drug 2 and control drug 6).
[0229] Test Example 9: Anti-aging and beauty test of Polygonatum cyrtonema extract
[0230] 1. Experimental Materials
[0231] Test drug 1: Extract I prepared according to the conditions of Example 3.
[0232] Test drug 2: Extract II prepared according to the conditions of Example 3.
[0233] Test drug 3: Extract III prepared according to the conditions of Example 3.
[0234] Test drug 4: PF prepared according to the conditions of Example 3.
[0235] Control drug 1: Polygonatum cyrtonema polysaccharide prepared according to patent technology (application number 202210621078.X);
[0236] Control drug 2: fresh Polygonatum cyrtonema raw material without steaming, and extract I prepared according to Example 4.
[0237] Control drug 3: wine-processed Polygonatum cyrtonema, extract I prepared according to comparative example 1.
[0238] Control drug 4: Extract I of nine-steamed and nine-processed Polygonatum cyrtonema, prepared according to Comparative Example 1.
[0239] Control drug 5: Extract I of Polygonatum cyrtonema prepared from black beans, prepared according to Comparative Example 1.
[0240] Control drug 6: Polygonatum sibiricum and Coix seeds complex, extract I prepared according to Comparative Example 1.
[0241] 2. Experimental methods
[0242] Experimental animals: 120 male 6-week-old SPF-grade KM mice, weighing 27-29 g, were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd. All mice were raised in an environment with a temperature of (22±1)°C, relative humidity of 40%-60%, and a light intensity of 12h / 12h alternating light and dark.
[0243] The drug was stirred until completely dissolved and stored in a refrigerator at 4°C. KM mice were given free drinking water and diet every day. After one week of adaptive feeding, they were randomly divided into 12 groups, with 10 mice in each group. One group was the normal control group, and the rest were the model group and the drug group. The mice in the model group and the drug group were subcutaneously injected with galacturonic acid (500 mg / Kg), the model group was orally administered with distilled water, and the drug group was given drugs: Polygonatum cyrtonema extract I group (1700 mg / Kg), Polygonatum cyrtonema extract II group (1360 mg / Kg), Polygonatum cyrtonema extract III group (136 mg / Kg), PF group (70 mg / Kg), control group 1 (70 mg / Kg), control drug 2 (1700 mg / Kg), control drug 3 (1700 mg / Kg), control drug 4 (1700 mg / Kg), control drug 5 (1700 mg / Kg), and control drug 6 (1700 mg / Kg). After continuous administration for 60 days, the mice were killed and the back skin was removed to detect skin moisture (Zhong Biluan et al. Study on the anti-aging effect of red croaker collagen on the skin of D-galactose-induced aged mice. Daily Chemical Industry, 2024, 54(05): 550-557), subcutaneous Hyp (Zeng Zhijun et al. Study on the anti-aging effect of ethanol extract of golden thread lotus on naturally aged mice. Chinese Medicinal Materials, 2020, 43(05): 1200-1204) and MMP-9 (Jiang Xiaoxia et al. Research progress on matrix metalloproteinases in the mechanism of ultraviolet-induced skin damage. Skin Diseases and Venereology, 2017, 39(05): 335-339). The relevant results are shown in Table 8 below.
[0244] Table 8 Results of drug cosmetic experiments
[0245]
[0246] Note: Compared with the blank group, Δ P<0.05, ΔΔ P<0.01; compared with the model group, * P<0.05, ** P<0.01.
[0247] The experimental results in Table 8 show that the water content of the model group decreased significantly compared with the blank control (ΔΔ P<0.01), Hyp (hydroxyproline, representing subcutaneous collagen) decreased significantly ( ΔΔ P<0.01, MMP-9 increased significantly ( Δ P<0.05), indicating that the model was successfully established. Compared with the model group, each drug group had the effects of increasing skin moisture content, increasing skin collagen content, and reducing MMP-9 activity. The polygonatum extracts and PF processed by this process in each drug group had the effects of delaying skin aging and beautifying (*P<0.05); extract I had the best effect of delaying skin aging and beautifying (**P<0.01), which may be related to the fact that the extract contained other ingredients that delayed skin aging and beautified in addition to PF; similarly, extracts II and III also had good effects of delaying skin aging and beautifying, both reaching extremely significant levels (**P<0.01); extract I had better effects of delaying skin aging and beautifying than extracts II, III and PF, which may be related to the fact that the extract contained more abundant other ingredients (comparison of test drugs 1-3). The polygonatum sibiricum prepared by the present process has better skin aging delay and beauty effects than the patented technology (test drug 5 and control drug 1); the extract I obtained by the present process has significantly better skin aging delay and beauty effects than the unprocessed polygonatum sibiricum extract (test drug 1 and control drug 2, Δ P<0.05); compared with the large-leaf polygonatum processed by traditional technology, the large-leaf polygonatum processed by this processing technology has better beauty effect than the processing technology, some indicators (maintaining skin moisture and hydroxyproline) increased significantly, and some indicators had little difference (compared with the control group 3-6); the effect of the complex of polygonatum and coix seed is the same as that of the unprocessed large-leaf polygonatum (control drug 2 and control drug 6).
[0248] The serial numbers of the above embodiments of the present invention are only for description and do not represent the advantages or disadvantages of the embodiments.
[0249] The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementation modes, which are merely illustrative rather than restrictive. Under the guidance of the present invention, ordinary technicians in this field can also make many forms without departing from the scope of protection of the present invention and the claims, all of which are within the protection of the present invention.
Claims
1. A method of preparing Polygonatum cyrtonema, characterized in that: The large-leaf Polygonatum is prepared by processing with coix seeds.
2. A processed Polygonatum cyrtonema as claimed in claim 1, characterized in that: The method for preparing large-leaf polygonatum with coix seed is as follows: wash and slice fresh large-leaf polygonatum, and dehydrate to a moisture content of less than 50%; then mix evenly with coix seed juice and steam for 10-30 hours, dehydrate the steamed large-leaf polygonatum to a moisture content of less than 50%, and obtain processed large-leaf polygonatum.
3. A prepared Polygonatum cyrtonema extract as claimed in claim 1 or 2, characterized in that: The extract of processed Polygonatum cyrtonema contains polyfructose derivatives, among which the typical representative molecular weight is 828.
4. A prepared Polygonatum cyrtonema extract as claimed in claim 3, characterized in that: The extraction method of the extract comprises the following steps: Step 1: Preparation of Extract I: reflux extraction of Polygonatum cyrtonema steamed with coix seeds and then concentrate to obtain Coix seeds-prepared Polygonatum cyrtonema extract I; Step 2: Preparation of Extract II: Decolorizing Extract I by stirring with activated carbon to obtain Coix Seed-processed Polygonatum cyrtonema Extract II; Step 3: Preparation of Extract III: Concentrate Extract II after dialyzing to obtain Coix Seed-processed Polygonatum cyrtonema Extract III; Step 4: Preparation of Polygonatum cyrtonemae polysaccharide prepared from coix seed, extracting extract III with a chromatography column and eluting, collecting the eluate with polysaccharide elution peak, dialyzing and freeze-drying to obtain Polygonatum cyrtonemae polysaccharide prepared from coix seed.
5. A prepared Polygonatum cyrtonema extract as claimed in claim 4, characterized in that: In step 1, 3-10 times the amount of water is used to reflux extract the steamed Polygonatum cyrtonema from coix seeds for 30-60 minutes, and filtered; the residue is extracted three times continuously; the three extracts are combined; and the extracts are concentrated under reduced pressure to a paste state, which is the Polygonatum cyrtonema extract I prepared from coix seeds.
6. A prepared Polygonatum cyrtonema extract as claimed in claim 4, characterized in that: In step 2, the coix seed-processed Polygonatum cyrtonema extract I is dissolved in water to form a 10% solution, 0.01-1% activated carbon is added, and the solution is stirred and decolorized at 40-90° C. for 10-60 minutes, and filtered to obtain the coix seed-processed Polygonatum cyrtonema extract II.
7. The prepared Polygonatum cyrtonema extract according to claim 4, characterized in that: In step three, the coix seed-processed Polygonatum cyrtonema extract II is dissolved in water; then dialyzed with a dialysis bag with a dialysis molecular weight of 200, and the solution in the dialysis bag is collected; the solution in the dialysis bag is dialyzed again with a dialysis bag with a dialysis molecular weight of 5000, and the solution outside the dialysis bag is collected and concentrated to dryness to obtain the coix seed-processed Polygonatum cyrtonema extract III.
8. The prepared Polygonatum cyrtonema extract according to claim 4, characterized in that: In step 4, the coix seed-processed large-leaf Polygonatum cyrtone extract III is dissolved with ultrapure water, and then loaded onto a Sephadex G-25 chromatography column placed in a 4°C chromatography cabinet, and eluted with ultrapure water. The flow rate during elution is controlled at 0.5 mL / min, and 10 mL of eluate is collected in each tube. Then, sugars are detected at 490 nm using the sulfuric acid-anthrone method tube by tube, and the tubes with polysaccharide peaks are collected and loaded into a dialysis bag with a molecular weight cutoff of 100 Da. The tubes are dialyzed with 10 times the amount of ultrapure water for 1 day, the water is changed every 3 hours, and then freeze-dried to obtain coix seed-processed large-leaf Polygonatum cyrtone polysaccharide.
9. Use of the processed Polygonatum cyrtonema as claimed in claim 1 or 2 or the processed Polygonatum cyrtonema extract as claimed in any one of claims 3 to 8 in the preparation of drugs for beauty, anti-aging, memory enhancement, prevention of Alzheimer's disease, anti-oxidation, anti-fatigue, hypoglycemic and the like.
Citation Information
Patent Citations
Rhizoma polygonati pearl barley tea
CN102940078A
Preserved rhizoma polygonati and preparation method thereof
CN106214961A
Polygonatum kingianum product and preparation method and application thereof
CN111743970A
Polygonatum sibiricum extract with effects of enhancing memory and preventing senile dementia as well as preparation method and application of polygonatum sibiricum extract
CN115944686A
Prepared polygonatum sibiricum extract, prepared polygonatum sibiricum polysaccharide and application of prepared polygonatum sibiricum extract and prepared polygonatum sibiricum polysaccharide in aspects of prolonging life and beautifying skin
CN118987117A
Cited By
Prepared polygonatum sibiricum extract, prepared polygonatum sibiricum polysaccharide and application of prepared polygonatum sibiricum extract and prepared polygonatum sibiricum polysaccharide in aspects of prolonging life and beautifying skin
CN118987117A
